logo
15:59 Apr 29

Divi's Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
6108.00
+81.50 (+1.35%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Divi's Laboratories Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
6108.00
+81.50 (+1.35%)
15:59 Apr 29
Quality
image/svg+xml

59/100
High Financial Strength

Valuation
image/svg+xml

12/100
Expensive Valuation

Technical

61/100
Technically Moderately Bullish

Strength

9

Weakness

6

Opportunity

1

Threats

0

11.78 %

ROE %

10.34 %

ROA %

77.86

EPS

512.11

BVPS

20.39 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM 2024
Net Sales
6969.4 8959.83 7767.51 7845 9078
Operating Expenses +
4109.46 5077.89 5399.69 5640 6266
Raw Material
2402.75 3490.97 3030.69 3238 3794
Increase Decrease in Cost
-78.67 -523.83 23.03 -109 -148
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
825.76 946.16 975.02 1094 1190
Miscellaneous Expenses
970.24 1193.41 1415.61 1429 1430
Operating Profit
2859.94 3881.94 2367.82 2205 2812
Other Income
62.56 113.87 344.66 339 346
Depreciation
255.59 311.51 343.18 378 390
Interest
0.87 0.8 0.67 3 3
Profit before tax and exceptio..
2666.04 3683.5 2368.63 2163 2765
Exceptional Items
0 0 0 0 0
PBT
2666.04 3683.5 2368.63 2163 2765
Provision for Taxation
681.75 723.05 545.25 563 698
Net Profit
1984.29 2960.45 1823.38 1600 2067
NET Profit after MI
1984.29 2960.45 1823.38 1600 2067
EPS
74.75 111.52 68.69 60.27 77.85
Operating Profit Margin (%)
41.04 43.33 30.48 28.11 30.98
Net Profit Margin (%)
28.47 33.04 23.47 20.4 22.77

ShareHolding

Promoter

FII

Public

Mutual Funds

Other Institutions

All Data in Percentage (%)

Mar 25 Dec 24 Sep 24 Jun 24 Mar 24
Promoter 51.90 51.90 51.90 51.90 51.90
FII 18.00 18.00 17.20 16.20 14.70
MF 12.80 11.90 11.90 13.10 14.30
Public 9.40 9.60 9.80 10.20 11.20
Others 0.00 0.00 0.00 0.00 0.00
Others 7.90 8.60 9.20 8.60 7.90
Shareholder Shares Holding %
Research 360 logo

Download Our App On: